People on the Move
Quintiles
Stella Blackburn will join Quintiles as VP and global head of risk management for its Real World and Late Phase Research group. She has worked for the European Medicines Agency (EMA) for 16 years, most recently in risk management development roles, where she liaised with biopharma companies and government bodies on pharmacovigilance and pharmacoepidemiology issues.
Blackburn studied medicine at the University of Cambridge and Guy’s Hospital, and has lectured and written textbooks on pharmaceutical risk management.
Quintiles’ Real World and Late Phase department, which Blackburn is to join, covers interventional phase IIIB and IV trials, prospective observational studies, and observational studies using electronic medical records.
The outsourcing firm was chosen this week by BioDelivery Sciences International to support the launch of its opioid-dependence drug.